A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy

计划入组 41 人 · 首次发布于 2021 年 7 月 12 日

Transbronchial Lung Biopsy Guided by ENB

计划入组 226 人 · 首次发布于 2018 年 8 月 14 日

Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer

计划入组 583 人 · 首次发布于 2008 年 5 月 7 日

MRL-871

UCM-871

TN-871

ENB Therapeutics, Inc.

United States

Pharmtechnology, LLC

Belarus

UZ Leuven

Belgium

Engine Biosciences and EDDC Form Strategic Partnership to Develop Precision Cancer Therapies

Cerevel Therapeutics Advances Emraclidine Development for Alzheimer's-Related Dementia and Psychosis

Fresenius Launches €200M+ Corporate Venture Fund to Tap Early-Stage Healthcare Innovation